 Duncan Wilcox
Concepts (515)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 25 | 2023 | 180 | 5.280 |
Why?
| | Cloaca | 16 | 2023 | 49 | 3.680 |
Why?
| | Urologic Surgical Procedures | 16 | 2022 | 94 | 3.170 |
Why?
| | Hypospadias | 7 | 2022 | 26 | 3.110 |
Why?
| | Urinary Bladder Neck Obstruction | 5 | 2023 | 21 | 2.530 |
Why?
| | Urogenital Abnormalities | 9 | 2023 | 48 | 2.430 |
Why?
| | Lower Urinary Tract Symptoms | 5 | 2021 | 47 | 1.930 |
Why?
| | Urinary Bladder, Neurogenic | 5 | 2022 | 32 | 1.860 |
Why?
| | Urethra | 10 | 2020 | 58 | 1.820 |
Why?
| | Anorectal Malformations | 8 | 2022 | 101 | 1.700 |
Why?
| | Hydronephrosis | 5 | 2015 | 30 | 1.670 |
Why?
| | Urodynamics | 5 | 2019 | 31 | 1.560 |
Why?
| | Urogenital System | 3 | 2023 | 16 | 1.540 |
Why?
| | Ureteral Obstruction | 5 | 2022 | 59 | 1.450 |
Why?
| | Urinary Bladder, Overactive | 2 | 2021 | 20 | 1.410 |
Why?
| | Spinal Dysraphism | 6 | 2017 | 44 | 1.390 |
Why?
| | Urology | 6 | 2023 | 48 | 1.330 |
Why?
| | Kidney | 13 | 2023 | 1351 | 1.200 |
Why?
| | Circumcision, Male | 2 | 2019 | 17 | 1.170 |
Why?
| | Lactams, Macrocyclic | 2 | 2017 | 47 | 1.140 |
Why?
| | Benzoquinones | 2 | 2017 | 44 | 1.140 |
Why?
| | Urologic Surgical Procedures, Male | 3 | 2022 | 27 | 1.130 |
Why?
| | Urinary Tract | 5 | 2016 | 40 | 1.120 |
Why?
| | Infant | 47 | 2022 | 8254 | 1.110 |
Why?
| | Pain, Postoperative | 4 | 2020 | 210 | 1.060 |
Why?
| | Hernias, Diaphragmatic, Congenital | 15 | 1998 | 189 | 1.060 |
Why?
| | Postoperative Complications | 17 | 2022 | 2230 | 1.030 |
Why?
| | Hernia, Diaphragmatic | 13 | 2000 | 68 | 1.010 |
Why?
| | Hirschsprung Disease | 8 | 2022 | 89 | 0.940 |
Why?
| | Reoperation | 10 | 2018 | 557 | 0.940 |
Why?
| | Tocotrienols | 1 | 2023 | 4 | 0.910 |
Why?
| | Male | 86 | 2023 | 57474 | 0.910 |
Why?
| | Urination | 4 | 2022 | 39 | 0.910 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2016 | 219 | 0.900 |
Why?
| | Child | 57 | 2023 | 19033 | 0.900 |
Why?
| | Urologic Diseases | 5 | 2018 | 36 | 0.900 |
Why?
| | Child, Preschool | 41 | 2020 | 9448 | 0.890 |
Why?
| | Rectum | 7 | 2023 | 155 | 0.860 |
Why?
| | Postoperative Care | 3 | 2019 | 237 | 0.860 |
Why?
| | Muscle, Smooth | 4 | 2017 | 157 | 0.850 |
Why?
| | Penis | 3 | 2019 | 37 | 0.830 |
Why?
| | Urinary Bladder Diseases | 4 | 2022 | 20 | 0.820 |
Why?
| | Disorders of Sex Development | 2 | 2019 | 37 | 0.800 |
Why?
| | Humans | 131 | 2023 | 118251 | 0.800 |
Why?
| | Anger | 1 | 2021 | 59 | 0.790 |
Why?
| | Kidney Pelvis | 3 | 2022 | 20 | 0.780 |
Why?
| | Urinary Incontinence | 4 | 2015 | 61 | 0.780 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2021 | 19 | 0.770 |
Why?
| | Cystostomy | 3 | 2017 | 8 | 0.770 |
Why?
| | TRPV Cation Channels | 1 | 2021 | 30 | 0.760 |
Why?
| | Constipation | 1 | 2021 | 76 | 0.730 |
Why?
| | Calcium Channels | 1 | 2021 | 149 | 0.720 |
Why?
| | Anal Canal | 5 | 2009 | 83 | 0.710 |
Why?
| | Retrospective Studies | 43 | 2023 | 12929 | 0.710 |
Why?
| | Follow-Up Studies | 23 | 2018 | 4574 | 0.690 |
Why?
| | Female | 79 | 2023 | 61261 | 0.690 |
Why?
| | Ureter | 5 | 2019 | 32 | 0.680 |
Why?
| | Receptors, Purinergic P2X1 | 1 | 2018 | 3 | 0.670 |
Why?
| | Cholinergic Fibers | 1 | 2018 | 19 | 0.660 |
Why?
| | Receptors, Muscarinic | 1 | 2018 | 18 | 0.660 |
Why?
| | Cryptorchidism | 4 | 2023 | 12 | 0.660 |
Why?
| | Photography | 1 | 2019 | 93 | 0.660 |
Why?
| | Intestine, Large | 1 | 2018 | 15 | 0.650 |
Why?
| | Genitalia, Female | 2 | 2018 | 40 | 0.640 |
Why?
| | Laparoscopy | 6 | 2022 | 417 | 0.640 |
Why?
| | Vesico-Ureteral Reflux | 4 | 2012 | 21 | 0.640 |
Why?
| | Muscle Contraction | 2 | 2019 | 413 | 0.630 |
Why?
| | Vagina | 3 | 2023 | 150 | 0.610 |
Why?
| | Perioperative Care | 2 | 2018 | 131 | 0.610 |
Why?
| | Fecal Incontinence | 5 | 2018 | 76 | 0.600 |
Why?
| | Urination Disorders | 2 | 2015 | 13 | 0.600 |
Why?
| | Anesthetics, Local | 2 | 2015 | 85 | 0.600 |
Why?
| | Preoperative Care | 3 | 2011 | 332 | 0.600 |
Why?
| | Pulmonary Surfactants | 9 | 2000 | 98 | 0.590 |
Why?
| | Treatment Outcome | 23 | 2022 | 9319 | 0.590 |
Why?
| | Clitoris | 1 | 2016 | 9 | 0.550 |
Why?
| | Infant, Newborn | 28 | 2020 | 5230 | 0.550 |
Why?
| | Intermittent Urethral Catheterization | 1 | 2015 | 3 | 0.540 |
Why?
| | Ultrasonography, Prenatal | 7 | 2014 | 227 | 0.520 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2011 | 33 | 0.510 |
Why?
| | Gastrointestinal Diseases | 1 | 2016 | 186 | 0.490 |
Why?
| | Nephrectomy | 5 | 2009 | 162 | 0.490 |
Why?
| | Infusion Pumps | 1 | 2013 | 32 | 0.480 |
Why?
| | Colon | 4 | 2023 | 237 | 0.480 |
Why?
| | Recovery of Function | 1 | 2018 | 603 | 0.480 |
Why?
| | Creatinine | 1 | 2015 | 491 | 0.460 |
Why?
| | Animals | 29 | 2023 | 33152 | 0.450 |
Why?
| | Enema | 2 | 2006 | 39 | 0.440 |
Why?
| | Prospective Studies | 13 | 2022 | 6443 | 0.440 |
Why?
| | Paraphimosis | 1 | 2012 | 1 | 0.440 |
Why?
| | Cadherins | 1 | 2014 | 186 | 0.440 |
Why?
| | Abnormalities, Multiple | 5 | 2006 | 182 | 0.430 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 244 | 0.430 |
Why?
| | Bandages | 1 | 2012 | 31 | 0.430 |
Why?
| | Pediatrics | 3 | 2017 | 980 | 0.430 |
Why?
| | Diagnostic Techniques, Urological | 1 | 2012 | 5 | 0.420 |
Why?
| | Analgesics, Opioid | 2 | 2020 | 789 | 0.420 |
Why?
| | Radioisotope Renography | 1 | 2011 | 4 | 0.410 |
Why?
| | Edema | 1 | 2012 | 124 | 0.400 |
Why?
| | Age Factors | 9 | 2019 | 2990 | 0.400 |
Why?
| | Surgical Sponges | 1 | 2011 | 3 | 0.400 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 4887 | 0.390 |
Why?
| | Stents | 1 | 2014 | 457 | 0.390 |
Why?
| | Dissection | 1 | 2011 | 55 | 0.380 |
Why?
| | Adolescent | 35 | 2023 | 18364 | 0.380 |
Why?
| | Guideline Adherence | 1 | 2015 | 520 | 0.380 |
Why?
| | Transition to Adult Care | 2 | 2023 | 58 | 0.380 |
Why?
| | Incidence | 6 | 2023 | 2413 | 0.370 |
Why?
| | Disease Models, Animal | 10 | 2018 | 3676 | 0.370 |
Why?
| | Registries | 1 | 2018 | 1806 | 0.360 |
Why?
| | Neurosurgical Procedures | 1 | 2011 | 164 | 0.350 |
Why?
| | Fetal Diseases | 3 | 2007 | 148 | 0.350 |
Why?
| | Bladder Exstrophy | 5 | 2007 | 16 | 0.350 |
Why?
| | Wilms Tumor | 3 | 2017 | 68 | 0.350 |
Why?
| | Sexual Dysfunction, Physiological | 2 | 2009 | 60 | 0.350 |
Why?
| | Cystitis | 1 | 2009 | 21 | 0.340 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 586 | 0.340 |
Why?
| | Doxorubicin | 2 | 2021 | 301 | 0.340 |
Why?
| | Surgical Wound Infection | 1 | 2011 | 251 | 0.330 |
Why?
| | Urethral Diseases | 3 | 2020 | 19 | 0.330 |
Why?
| | Ileum | 2 | 2006 | 100 | 0.330 |
Why?
| | Adrenal Hyperplasia, Congenital | 2 | 2005 | 29 | 0.320 |
Why?
| | Signal Transduction | 2 | 2021 | 4688 | 0.320 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2011 | 523 | 0.320 |
Why?
| | Mice | 12 | 2023 | 15446 | 0.320 |
Why?
| | Ureterocele | 1 | 2007 | 7 | 0.320 |
Why?
| | Digestive System Abnormalities | 2 | 2004 | 11 | 0.310 |
Why?
| | Robotic Surgical Procedures | 2 | 2022 | 89 | 0.310 |
Why?
| | Pulmonary Gas Exchange | 4 | 1998 | 117 | 0.310 |
Why?
| | Prenatal Diagnosis | 5 | 2007 | 167 | 0.300 |
Why?
| | Colon, Sigmoid | 5 | 2021 | 15 | 0.290 |
Why?
| | Cathartics | 1 | 2006 | 11 | 0.290 |
Why?
| | Urography | 1 | 2006 | 14 | 0.290 |
Why?
| | Urinary Bladder Fistula | 2 | 2022 | 10 | 0.290 |
Why?
| | Congenital Abnormalities | 3 | 2020 | 72 | 0.280 |
Why?
| | Vesicovaginal Fistula | 1 | 2005 | 3 | 0.280 |
Why?
| | Colorectal Neoplasms | 2 | 2022 | 628 | 0.270 |
Why?
| | Kidney Function Tests | 4 | 2015 | 163 | 0.260 |
Why?
| | Animals, Newborn | 6 | 2018 | 804 | 0.250 |
Why?
| | Hemorrhage | 1 | 2009 | 606 | 0.250 |
Why?
| | Kidney Neoplasms | 2 | 2009 | 333 | 0.250 |
Why?
| | Mass Screening | 1 | 2012 | 1048 | 0.250 |
Why?
| | Vincristine | 2 | 2022 | 99 | 0.250 |
Why?
| | Postnatal Care | 2 | 2015 | 68 | 0.250 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2004 | 56 | 0.240 |
Why?
| | Psychosocial Support Systems | 1 | 2023 | 12 | 0.240 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2022 | 122 | 0.230 |
Why?
| | Prognosis | 5 | 2018 | 3424 | 0.230 |
Why?
| | Fetus | 1 | 2007 | 690 | 0.230 |
Why?
| | Imaging, Three-Dimensional | 1 | 2006 | 500 | 0.220 |
Why?
| | Urinary Diversion | 3 | 2015 | 12 | 0.220 |
Why?
| | Lung | 6 | 1998 | 3623 | 0.220 |
Why?
| | Sacrum | 1 | 2003 | 67 | 0.220 |
Why?
| | Surgical Flaps | 1 | 2003 | 118 | 0.210 |
Why?
| | Muscle Development | 1 | 2003 | 102 | 0.210 |
Why?
| | Kidney Calices | 1 | 2001 | 1 | 0.210 |
Why?
| | Pain Measurement | 2 | 2015 | 468 | 0.210 |
Why?
| | Ultrasonography | 4 | 2015 | 714 | 0.210 |
Why?
| | Analgesia | 2 | 2020 | 81 | 0.210 |
Why?
| | Cell Hypoxia | 3 | 2014 | 217 | 0.210 |
Why?
| | Extracellular Matrix Proteins | 1 | 2003 | 132 | 0.210 |
Why?
| | Sheep | 11 | 1998 | 762 | 0.210 |
Why?
| | Digestive System Surgical Procedures | 2 | 2019 | 91 | 0.200 |
Why?
| | Testicular Neoplasms | 2 | 2019 | 95 | 0.200 |
Why?
| | Pregnancy Outcome | 2 | 2022 | 349 | 0.190 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2020 | 13 | 0.190 |
Why?
| | Gastrostomy | 2 | 1999 | 93 | 0.190 |
Why?
| | Hydrocephalus | 2 | 2011 | 81 | 0.190 |
Why?
| | Administration, Oral | 1 | 2023 | 753 | 0.190 |
Why?
| | Robotics | 1 | 2022 | 83 | 0.190 |
Why?
| | Intestinal Obstruction | 3 | 1997 | 41 | 0.190 |
Why?
| | Length of Stay | 4 | 2020 | 1027 | 0.190 |
Why?
| | Colitis, Ulcerative | 2 | 2021 | 105 | 0.190 |
Why?
| | Prune Belly Syndrome | 2 | 2011 | 9 | 0.180 |
Why?
| | Orchiopexy | 1 | 2019 | 5 | 0.180 |
Why?
| | Risk Assessment | 5 | 2017 | 3043 | 0.180 |
Why?
| | Perinatology | 1 | 1999 | 5 | 0.180 |
Why?
| | Hypertrophy | 2 | 2019 | 121 | 0.180 |
Why?
| | Cell Division | 1 | 2002 | 775 | 0.180 |
Why?
| | Smooth Muscle Myosins | 1 | 2019 | 8 | 0.170 |
Why?
| | Nephrology Nursing | 1 | 2019 | 5 | 0.170 |
Why?
| | Atlases as Topic | 1 | 2019 | 9 | 0.170 |
Why?
| | Muscle Relaxation | 1 | 2019 | 32 | 0.170 |
Why?
| | Nephrostomy, Percutaneous | 1 | 1999 | 9 | 0.170 |
Why?
| | Myosin Light Chains | 1 | 2019 | 35 | 0.170 |
Why?
| | Nephrology | 1 | 1999 | 50 | 0.170 |
Why?
| | Extracellular Matrix | 1 | 2003 | 444 | 0.170 |
Why?
| | Diet | 1 | 2006 | 1143 | 0.170 |
Why?
| | Pediatric Nursing | 1 | 2019 | 40 | 0.170 |
Why?
| | Anxiety, Separation | 1 | 2018 | 17 | 0.170 |
Why?
| | Maternal Deprivation | 1 | 2018 | 14 | 0.170 |
Why?
| | Umbilicus | 1 | 1998 | 15 | 0.170 |
Why?
| | Twins, Conjoined | 1 | 1998 | 6 | 0.160 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2019 | 114 | 0.160 |
Why?
| | Sex Factors | 4 | 2017 | 1765 | 0.160 |
Why?
| | Glomerular Filtration Rate | 3 | 2015 | 681 | 0.160 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 119 | 0.160 |
Why?
| | Reflex | 1 | 2018 | 64 | 0.160 |
Why?
| | Phospholipids | 2 | 1997 | 207 | 0.160 |
Why?
| | Medical Errors | 1 | 2019 | 88 | 0.160 |
Why?
| | Diagnostic Errors | 1 | 2019 | 162 | 0.160 |
Why?
| | Intestinal Pseudo-Obstruction | 2 | 1997 | 7 | 0.160 |
Why?
| | Phosphatidylcholines | 2 | 1997 | 131 | 0.160 |
Why?
| | Reference Values | 2 | 2018 | 770 | 0.160 |
Why?
| | Urinary Catheterization | 2 | 2001 | 24 | 0.150 |
Why?
| | Kidney Diseases | 4 | 2009 | 439 | 0.150 |
Why?
| | Genitalia, Male | 1 | 1997 | 11 | 0.150 |
Why?
| | Informed Consent | 1 | 1998 | 162 | 0.150 |
Why?
| | Time Factors | 6 | 2019 | 6368 | 0.150 |
Why?
| | Case-Control Studies | 3 | 2020 | 3156 | 0.150 |
Why?
| | Cancer Survivors | 1 | 2021 | 201 | 0.150 |
Why?
| | Urologic Neoplasms | 1 | 2017 | 25 | 0.150 |
Why?
| | Peptic Ulcer Perforation | 1 | 1997 | 2 | 0.150 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1997 | 7 | 0.150 |
Why?
| | Peptic Ulcer Hemorrhage | 1 | 1997 | 6 | 0.150 |
Why?
| | Duodenal Ulcer | 1 | 1997 | 9 | 0.150 |
Why?
| | Cholelithiasis | 1 | 1997 | 30 | 0.150 |
Why?
| | Catheterization | 2 | 2013 | 164 | 0.150 |
Why?
| | Algorithms | 3 | 2018 | 1522 | 0.150 |
Why?
| | Gallstones | 1 | 1997 | 26 | 0.150 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 251 | 0.150 |
Why?
| | Postoperative Period | 1 | 2018 | 307 | 0.150 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1590 | 0.140 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2017 | 211 | 0.140 |
Why?
| | Vulva | 1 | 2016 | 24 | 0.140 |
Why?
| | Patient Safety | 1 | 2019 | 281 | 0.140 |
Why?
| | Risk Factors | 3 | 2018 | 8958 | 0.140 |
Why?
| | Endoscopy | 1 | 1998 | 271 | 0.140 |
Why?
| | Outpatients | 1 | 2019 | 324 | 0.140 |
Why?
| | Fluorocarbons | 1 | 1997 | 100 | 0.130 |
Why?
| | Medical Oncology | 1 | 2017 | 229 | 0.130 |
Why?
| | Phosphatidylglycerols | 1 | 1995 | 20 | 0.130 |
Why?
| | Sphingomyelins | 1 | 1995 | 29 | 0.130 |
Why?
| | Infusion Pumps, Implantable | 1 | 2015 | 20 | 0.130 |
Why?
| | Young Adult | 8 | 2023 | 10731 | 0.130 |
Why?
| | Gynecologic Surgical Procedures | 3 | 2021 | 49 | 0.130 |
Why?
| | Pneumothorax | 1 | 1995 | 48 | 0.130 |
Why?
| | Toothbrushing | 1 | 1994 | 5 | 0.130 |
Why?
| | Testis | 2 | 2023 | 144 | 0.130 |
Why?
| | Lung Compliance | 2 | 1995 | 49 | 0.130 |
Why?
| | Attitude to Health | 1 | 1998 | 410 | 0.130 |
Why?
| | Amniotic Fluid | 1 | 1995 | 68 | 0.130 |
Why?
| | Bulimia | 1 | 1994 | 26 | 0.130 |
Why?
| | Desmin | 2 | 2006 | 31 | 0.130 |
Why?
| | Appendix | 3 | 2001 | 28 | 0.120 |
Why?
| | Scrotum | 2 | 2007 | 25 | 0.120 |
Why?
| | Cell Differentiation | 1 | 2002 | 1746 | 0.120 |
Why?
| | Triiodothyronine | 1 | 1994 | 43 | 0.120 |
Why?
| | Bone and Bones | 1 | 1997 | 288 | 0.120 |
Why?
| | Sensitivity and Specificity | 3 | 2011 | 1787 | 0.120 |
Why?
| | Laparotomy | 1 | 1994 | 105 | 0.120 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1469 | 0.120 |
Why?
| | Pilot Projects | 1 | 2019 | 1405 | 0.120 |
Why?
| | Organ Size | 2 | 2014 | 460 | 0.120 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 400 | 0.120 |
Why?
| | Meconium | 1 | 1993 | 7 | 0.120 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 379 | 0.120 |
Why?
| | ROC Curve | 2 | 2015 | 470 | 0.120 |
Why?
| | Anastomosis, Surgical | 5 | 2020 | 146 | 0.120 |
Why?
| | Phenyl Ethers | 1 | 1993 | 3 | 0.120 |
Why?
| | Pregnancy | 10 | 2022 | 5671 | 0.120 |
Why?
| | Respiration, Artificial | 1 | 1997 | 543 | 0.120 |
Why?
| | Foreign Bodies | 1 | 1994 | 98 | 0.120 |
Why?
| | Foreign-Body Migration | 2 | 2011 | 37 | 0.110 |
Why?
| | Logistic Models | 1 | 2018 | 1896 | 0.110 |
Why?
| | Perineum | 2 | 2019 | 29 | 0.110 |
Why?
| | Foreskin | 1 | 2012 | 6 | 0.110 |
Why?
| | Nitric Oxide | 2 | 1997 | 891 | 0.110 |
Why?
| | Syndrome | 2 | 2007 | 343 | 0.110 |
Why?
| | Fertility | 2 | 2022 | 135 | 0.110 |
Why?
| | Infant Food | 1 | 1993 | 63 | 0.110 |
Why?
| | Fetal Blood | 1 | 1994 | 270 | 0.110 |
Why?
| | Hydrocortisone | 1 | 1994 | 272 | 0.110 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 175 | 0.110 |
Why?
| | Apoptosis | 1 | 2002 | 2461 | 0.110 |
Why?
| | Comorbidity | 2 | 2016 | 1516 | 0.110 |
Why?
| | Receptor, Muscarinic M3 | 1 | 2011 | 2 | 0.100 |
Why?
| | Adult | 12 | 2022 | 31324 | 0.100 |
Why?
| | Metabolism, Inborn Errors | 1 | 2011 | 38 | 0.100 |
Why?
| | Genitalia | 2 | 2019 | 27 | 0.100 |
Why?
| | Shock | 1 | 1993 | 91 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2659 | 0.100 |
Why?
| | Pain Management | 1 | 2013 | 293 | 0.100 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 1857 | 0.100 |
Why?
| | Parents | 1 | 1998 | 1208 | 0.090 |
Why?
| | Hernia, Ventral | 1 | 2010 | 19 | 0.090 |
Why?
| | Databases, Factual | 3 | 2019 | 1196 | 0.090 |
Why?
| | Genetic Therapy | 1 | 2011 | 267 | 0.090 |
Why?
| | Ischemia | 1 | 1993 | 370 | 0.090 |
Why?
| | Acute Disease | 1 | 2012 | 933 | 0.090 |
Why?
| | Urinary Reservoirs, Continent | 2 | 2016 | 5 | 0.090 |
Why?
| | Campomelic Dysplasia | 1 | 2009 | 2 | 0.090 |
Why?
| | Dysgerminoma | 1 | 2009 | 3 | 0.090 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 204 | 0.090 |
Why?
| | BK Virus | 1 | 2009 | 15 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 562 | 0.090 |
Why?
| | Urolithiasis | 1 | 2009 | 8 | 0.090 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1681 | 0.090 |
Why?
| | Hyperbaric Oxygenation | 1 | 2009 | 39 | 0.090 |
Why?
| | Polyomavirus Infections | 1 | 2009 | 22 | 0.080 |
Why?
| | SOX9 Transcription Factor | 1 | 2009 | 24 | 0.080 |
Why?
| | Tumor Virus Infections | 1 | 2009 | 41 | 0.080 |
Why?
| | Bronchoalveolar Lavage Fluid | 3 | 1997 | 605 | 0.080 |
Why?
| | Cohort Studies | 2 | 2016 | 5078 | 0.080 |
Why?
| | Ureterostomy | 1 | 2007 | 3 | 0.080 |
Why?
| | Disease Progression | 1 | 2015 | 2477 | 0.080 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 244 | 0.080 |
Why?
| | Nanoparticles | 1 | 2011 | 324 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2012 | 690 | 0.080 |
Why?
| | Liver Neoplasms | 1 | 2011 | 526 | 0.080 |
Why?
| | Neoplasms | 1 | 2021 | 2160 | 0.070 |
Why?
| | Urogenital Neoplasms | 1 | 2006 | 5 | 0.070 |
Why?
| | Myogenin | 1 | 2006 | 13 | 0.070 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 149 | 0.070 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2006 | 17 | 0.070 |
Why?
| | Pulmonary Artery | 4 | 1997 | 1055 | 0.070 |
Why?
| | Hematocolpos | 1 | 2005 | 3 | 0.070 |
Why?
| | Analysis of Variance | 3 | 2009 | 1288 | 0.070 |
Why?
| | Calcinosis | 1 | 2009 | 282 | 0.070 |
Why?
| | Colonic Neoplasms | 1 | 2007 | 224 | 0.070 |
Why?
| | Fetal Organ Maturity | 2 | 1995 | 26 | 0.060 |
Why?
| | Malabsorption Syndromes | 1 | 2004 | 14 | 0.060 |
Why?
| | Defecation | 1 | 2004 | 18 | 0.060 |
Why?
| | Nutritional Support | 1 | 2004 | 28 | 0.060 |
Why?
| | Gestational Age | 3 | 2004 | 765 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1433 | 0.060 |
Why?
| | Biomarkers | 1 | 2014 | 3567 | 0.060 |
Why?
| | Menstruation Disturbances | 1 | 2003 | 12 | 0.060 |
Why?
| | Ovarian Neoplasms | 1 | 2009 | 420 | 0.060 |
Why?
| | Salvage Therapy | 1 | 2004 | 130 | 0.060 |
Why?
| | Coitus | 1 | 2003 | 28 | 0.060 |
Why?
| | Decision Support Techniques | 1 | 2007 | 364 | 0.060 |
Why?
| | Rabbits | 2 | 1996 | 779 | 0.060 |
Why?
| | Urologists | 1 | 2023 | 18 | 0.060 |
Why?
| | Steroid 21-Hydroxylase | 1 | 2003 | 29 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 4684 | 0.060 |
Why?
| | Urethral Obstruction | 1 | 2003 | 9 | 0.060 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2003 | 15 | 0.060 |
Why?
| | Methyl Green | 1 | 2003 | 1 | 0.060 |
Why?
| | Colostomy | 3 | 2004 | 26 | 0.060 |
Why?
| | Eosine Yellowish-(YS) | 1 | 2003 | 6 | 0.060 |
Why?
| | Ascites | 1 | 2003 | 37 | 0.060 |
Why?
| | Urine | 1 | 2003 | 58 | 0.060 |
Why?
| | Azo Compounds | 1 | 2003 | 25 | 0.060 |
Why?
| | Urothelium | 1 | 2003 | 33 | 0.060 |
Why?
| | Erectile Dysfunction | 1 | 2022 | 37 | 0.050 |
Why?
| | Endocrinology | 1 | 2003 | 68 | 0.050 |
Why?
| | Puberty | 1 | 2003 | 143 | 0.050 |
Why?
| | Fatal Outcome | 2 | 2007 | 286 | 0.050 |
Why?
| | Observer Variation | 1 | 2003 | 306 | 0.050 |
Why?
| | Mucous Membrane | 1 | 2003 | 112 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2015 | 2855 | 0.050 |
Why?
| | Epispadias | 1 | 2001 | 3 | 0.050 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2002 | 55 | 0.050 |
Why?
| | Dilatation, Pathologic | 2 | 2001 | 56 | 0.050 |
Why?
| | Blood Pressure | 4 | 1997 | 1656 | 0.050 |
Why?
| | Ureteral Diseases | 1 | 2001 | 3 | 0.050 |
Why?
| | Pulmonary Surfactant-Associated Proteins | 2 | 2000 | 10 | 0.050 |
Why?
| | Proteolipids | 2 | 2000 | 28 | 0.050 |
Why?
| | Learning Curve | 1 | 2022 | 67 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2007 | 807 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2022 | 416 | 0.050 |
Why?
| | Urinary Fistula | 1 | 2000 | 9 | 0.050 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 251 | 0.050 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 2000 | 31 | 0.050 |
Why?
| | Radiography | 1 | 2003 | 860 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2433 | 0.050 |
Why?
| | Blotting, Western | 1 | 2003 | 1186 | 0.050 |
Why?
| | Gastric Fistula | 1 | 1999 | 4 | 0.040 |
Why?
| | Jejunal Diseases | 1 | 1999 | 6 | 0.040 |
Why?
| | Intestinal Fistula | 1 | 1999 | 12 | 0.040 |
Why?
| | Intestines | 2 | 2020 | 330 | 0.040 |
Why?
| | Actins | 1 | 2002 | 400 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2019 | 10 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2019 | 9 | 0.040 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2019 | 26 | 0.040 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 61 | 0.040 |
Why?
| | Pelvis | 1 | 1999 | 92 | 0.040 |
Why?
| | Pulmonary Alveoli | 2 | 2000 | 375 | 0.040 |
Why?
| | Digestive System Diseases | 1 | 1998 | 26 | 0.040 |
Why?
| | Rectal Prolapse | 1 | 2018 | 18 | 0.040 |
Why?
| | Quality of Life | 1 | 2009 | 2355 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2018 | 21 | 0.040 |
Why?
| | Genital Diseases, Female | 1 | 2018 | 28 | 0.040 |
Why?
| | Cecostomy | 1 | 1998 | 3 | 0.040 |
Why?
| | Surgical Stomas | 1 | 1998 | 6 | 0.040 |
Why?
| | Drainage | 1 | 1999 | 158 | 0.040 |
Why?
| | Mutation | 1 | 2009 | 3435 | 0.040 |
Why?
| | Surgical Mesh | 1 | 1998 | 41 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2003 | 667 | 0.040 |
Why?
| | Sigmoid Diseases | 1 | 1997 | 9 | 0.040 |
Why?
| | Capillaries | 1 | 1998 | 102 | 0.040 |
Why?
| | Blood Gas Analysis | 1 | 1997 | 69 | 0.040 |
Why?
| | Cardiology Service, Hospital | 1 | 1997 | 29 | 0.040 |
Why?
| | Survival Analysis | 2 | 2017 | 1262 | 0.040 |
Why?
| | Ampulla of Vater | 1 | 1997 | 28 | 0.040 |
Why?
| | Ileal Diseases | 1 | 1996 | 9 | 0.040 |
Why?
| | Rhabdomyosarcoma | 1 | 2017 | 56 | 0.040 |
Why?
| | Duodenum | 1 | 1997 | 67 | 0.040 |
Why?
| | Stomach | 1 | 1997 | 103 | 0.040 |
Why?
| | Rectal Neoplasms | 2 | 1998 | 121 | 0.040 |
Why?
| | Teratoma | 1 | 2017 | 92 | 0.040 |
Why?
| | Barrett Esophagus | 1 | 1999 | 154 | 0.040 |
Why?
| | Rats | 2 | 1996 | 5339 | 0.040 |
Why?
| | Persistent Fetal Circulation Syndrome | 2 | 1995 | 132 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1202 | 0.030 |
Why?
| | Collagen | 2 | 1995 | 433 | 0.030 |
Why?
| | Umbilical Cord | 1 | 1996 | 84 | 0.030 |
Why?
| | Operative Time | 1 | 2016 | 114 | 0.030 |
Why?
| | Wound Healing | 1 | 1998 | 270 | 0.030 |
Why?
| | Clinical Protocols | 1 | 1997 | 234 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 649 | 0.030 |
Why?
| | NADPH Dehydrogenase | 1 | 1995 | 8 | 0.030 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1995 | 21 | 0.030 |
Why?
| | United States | 1 | 2011 | 12488 | 0.030 |
Why?
| | Tunica Intima | 1 | 1995 | 77 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1622 | 0.030 |
Why?
| | Middle Aged | 5 | 2021 | 27510 | 0.030 |
Why?
| | Proteins | 3 | 1995 | 935 | 0.030 |
Why?
| | Total Lung Capacity | 1 | 1994 | 33 | 0.030 |
Why?
| | Bupivacaine | 1 | 1994 | 34 | 0.030 |
Why?
| | Swine | 1 | 1996 | 719 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 1996 | 571 | 0.030 |
Why?
| | Mothers | 1 | 2020 | 675 | 0.030 |
Why?
| | Thoracotomy | 1 | 1994 | 83 | 0.030 |
Why?
| | Endothelins | 1 | 1994 | 62 | 0.030 |
Why?
| | Heart Diseases | 1 | 1997 | 340 | 0.030 |
Why?
| | Sigmoid Neoplasms | 1 | 1993 | 3 | 0.030 |
Why?
| | Gangrene | 1 | 1993 | 6 | 0.030 |
Why?
| | Hypertonic Solutions | 1 | 1993 | 8 | 0.030 |
Why?
| | Product Labeling | 1 | 1993 | 5 | 0.030 |
Why?
| | Disease Management | 1 | 2017 | 566 | 0.030 |
Why?
| | Ileostomy | 2 | 2004 | 18 | 0.030 |
Why?
| | Recurrence | 1 | 1995 | 971 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 1997 | 458 | 0.030 |
Why?
| | INDEL Mutation | 1 | 2011 | 14 | 0.030 |
Why?
| | Frameshift Mutation | 1 | 2011 | 28 | 0.030 |
Why?
| | Necrosis | 1 | 1993 | 230 | 0.030 |
Why?
| | Consanguinity | 1 | 2011 | 49 | 0.030 |
Why?
| | Colorado | 2 | 2018 | 4178 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2011 | 155 | 0.030 |
Why?
| | beta-Galactosidase | 1 | 2011 | 64 | 0.030 |
Why?
| | Mice, SCID | 1 | 2011 | 331 | 0.020 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 153 | 0.020 |
Why?
| | Colitis | 1 | 1993 | 219 | 0.020 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2000 | 241 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2013 | 609 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 1995 | 700 | 0.020 |
Why?
| | Tissue Survival | 1 | 2007 | 13 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2148 | 0.020 |
Why?
| | Cystectomy | 1 | 2007 | 32 | 0.020 |
Why?
| | Chronic Disease | 1 | 1993 | 1630 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2007 | 136 | 0.020 |
Why?
| | Colectomy | 1 | 2007 | 84 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 164 | 0.020 |
Why?
| | Microsurgery | 1 | 2007 | 64 | 0.020 |
Why?
| | Vaginal Neoplasms | 1 | 2006 | 11 | 0.020 |
Why?
| | Models, Molecular | 1 | 2011 | 1434 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 1998 | 1784 | 0.020 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2006 | 66 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2009 | 1163 | 0.020 |
Why?
| | Hydroxyproline | 2 | 1995 | 24 | 0.020 |
Why?
| | Elastin | 2 | 1995 | 77 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2011 | 2664 | 0.020 |
Why?
| | Duodenal Obstruction | 1 | 2004 | 5 | 0.020 |
Why?
| | Short Bowel Syndrome | 1 | 2004 | 19 | 0.020 |
Why?
| | Intestinal Atresia | 1 | 2004 | 16 | 0.020 |
Why?
| | Parenteral Nutrition, Total | 1 | 2004 | 39 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 2837 | 0.020 |
Why?
| | Enteritis | 1 | 2004 | 78 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2007 | 1379 | 0.010 |
Why?
| | Gender Identity | 1 | 2003 | 102 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1072 | 0.010 |
Why?
| | Aorta | 2 | 1995 | 364 | 0.010 |
Why?
| | Europe | 1 | 2003 | 355 | 0.010 |
Why?
| | Consensus | 1 | 2003 | 533 | 0.010 |
Why?
| | Body Weight | 1 | 2004 | 923 | 0.010 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2000 | 100 | 0.010 |
Why?
| | Societies, Medical | 1 | 2003 | 701 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 2006 | 939 | 0.010 |
Why?
| | Glycoproteins | 1 | 2000 | 317 | 0.010 |
Why?
| | Graft Survival | 1 | 2001 | 497 | 0.010 |
Why?
| | Leiomyoma | 1 | 1998 | 45 | 0.010 |
Why?
| | Compartment Syndromes | 1 | 1998 | 37 | 0.010 |
Why?
| | DNA | 2 | 1995 | 1385 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 4044 | 0.010 |
Why?
| | Blood-Air Barrier | 1 | 1998 | 9 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 172 | 0.010 |
Why?
| | Esophagoscopy | 1 | 1999 | 190 | 0.010 |
Why?
| | Venous Thrombosis | 1 | 1998 | 145 | 0.010 |
Why?
| | Constriction | 1 | 1996 | 46 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2002 | 514 | 0.010 |
Why?
| | Iatrogenic Disease | 1 | 1996 | 49 | 0.010 |
Why?
| | Hospitals, Veterans | 1 | 1997 | 245 | 0.010 |
Why?
| | Venules | 1 | 1995 | 13 | 0.010 |
Why?
| | Heart Septum | 1 | 1995 | 28 | 0.010 |
Why?
| | Arterioles | 1 | 1995 | 46 | 0.010 |
Why?
| | Pneumonia | 1 | 2000 | 579 | 0.010 |
Why?
| | Biopsy | 1 | 1999 | 1078 | 0.010 |
Why?
| | Heart Septal Defects, Atrial | 1 | 1995 | 50 | 0.010 |
Why?
| | Ductus Arteriosus, Patent | 1 | 1995 | 50 | 0.010 |
Why?
| | Heart Atria | 1 | 1995 | 112 | 0.010 |
Why?
| | Pleura | 1 | 1994 | 18 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 1995 | 226 | 0.010 |
Why?
| | Bronchi | 1 | 1995 | 241 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1998 | 709 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1995 | 528 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 1995 | 652 | 0.010 |
Why?
| | Hospital Mortality | 1 | 1997 | 811 | 0.010 |
Why?
| | Heparin | 1 | 1994 | 230 | 0.010 |
Why?
| | Echocardiography | 1 | 1994 | 556 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1995 | 725 | 0.010 |
Why?
| | Cystic Fibrosis | 1 | 1999 | 963 | 0.010 |
Why?
| | Aged | 2 | 1997 | 19594 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1993 | 6541 | 0.000 |
Why?
|
|
Wilcox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|